<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">Most cases of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are relatively mild or even asymptomatic (
 <xref rid="bib6" ref-type="bibr">Gandhi, Yokoe, &amp; Havlir, 2020</xref>; 
 <xref rid="bib7" ref-type="bibr">Killeen &amp; Kiware, 2020</xref>), and transmission can occur through such subtle mechanisms as droplets generated while speaking (
 <xref rid="bib1" ref-type="bibr">Anfinrud, Stadnytskyi, Bax, &amp; Bax, 2020</xref>) and persistence on contaminated surfaces (
 <xref rid="bib2" ref-type="bibr">van Doremalen etÂ al., 2020</xref>). Reactive containment interventions against SARS-CoV-2, based on testing and contact tracing, are therefore unlikely to succeed as a stand-alone containment measures (
 <xref rid="bib6" ref-type="bibr">Gandhi, Yokoe, &amp; Havlir, 2020</xref>; 
 <xref rid="bib7" ref-type="bibr">Killeen &amp; Kiware, 2020</xref>). Furthermore, it remains to be seen whether any sufficiently effective new vaccines or drugs can be developed, evaluated and made available globally in sufficient quantities soon enough to avert the worst consequences of the ongoing SARS-CoV-2 pandemic (
 <xref rid="bib10" ref-type="bibr">Rubin, Baden, &amp; Morrissey, 2020a</xref>). In the meantime, the only effective intervention options available to governments are various presumptive social distancing, hygiene and quarantine measures, enforced variations of which are often referred to as 
 <italic>lock down</italic>.
</p>
